The Hydration Pharmaceuticals Co (ASX:HPC) Asset Impairment Charge: A$0.00 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is The Hydration Pharmaceuticals Co Asset Impairment Charge?

The Hydration Pharmaceuticals Co ASX:HPC Asset Impairment Charge is A$0.00 Mil as of Dec. 2025. The stock has 3 warning signs investors should review.

The Hydration Pharmaceuticals Co's Asset Impairment Charge for the six months ended in Dec. 2025 was A$0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2025 was A$0.00 Mil.

The Hydration Pharmaceuticals Co Asset Impairment Charge Related Terms

The Hydration Pharmaceuticals Co Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for The Hydration Pharmaceuticals Co's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Hydration Pharmaceuticals Co Asset Impairment Charge Chart

The Hydration Pharmaceuticals Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Asset Impairment Charge
0.00 0.00 0.00 0.00 0.00

The Hydration Pharmaceuticals Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

The Hydration Pharmaceuticals Co Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

What does a Asset Impairment Charge of A$0.00 Mil mean?
The Hydration Pharmaceuticals Co (ASX:HPC) has a Asset Impairment Charge of A$0.00 Mil as of Dec. 2025.
Is The Hydration Pharmaceuticals Co's Asset Impairment Charge too high?
The Hydration Pharmaceuticals Co's current Asset Impairment Charge is A$0.00 Mil.
How does The Hydration Pharmaceuticals Co's Asset Impairment Charge compare to SYY and USFD?
The Hydration Pharmaceuticals Co's Asset Impairment Charge of A$0.00 Mil can be compared against companies in the Retail - Defensive industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Retail - Defensive company?
A good Asset Impairment Charge depends on the Retail - Defensive industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. The Hydration Pharmaceuticals Co's current Asset Impairment Charge is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Hydration Pharmaceuticals Co stock overvalued right now?
The Hydration Pharmaceuticals Co (ASX:HPC) has a current Asset Impairment Charge of A$0.00 Mil. The current Asset Impairment Charge is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For The Hydration Pharmaceuticals Co (ASX:HPC), the current Asset Impairment Charge is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Hydration Pharmaceuticals Co Business Description

Address 6 Palmer Parade, Level 2, Cremorne, Melbourne, VIC, AUS, 3121
The Hydration Pharmaceuticals Co Ltd is a consumer products company that markets and sells a range of liquid, tablet and powder Healthy Hydration Solutions products into the USA market, under the Hydralyte brand. Hydralyte collates and translates consumer insights and needs into developing and delivering quality hydration products to market. The Company's business model is an asset light, flexible production model that allows it to outsource manufacturing and packaging to appropriate suppliers.